Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.
30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00
52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91,961 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.63
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 15.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,59,66358.6% delivered
Lupin share news and announcements
2,113 announcements, routine notices left out, newest first. Page 39 of 43.
Jan 2010
29 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 125543 lacs for quarter ending on 31-DEC-2009 against Rs. 96184 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 16060 lacs for the quarter ending on 31-DEC-2009 against Rs. 11650 lacs for the quarter ending on 31-DEC-2008.29 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 100450 lacs for quarter ending on 31-DEC-2009 against Rs. 72886 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 22270 lacs for the quarter ending on 31-DEC-2009 against Rs. 8814 lacs for the quarter ending on 31-DEC-2008.28 Jan · Business
Press release dated January 28, 2010, titled "Lupin receives US FDA approval for Perindopril Erbumine Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jan · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on January 22, 2010 has allotted 15617 fully paid up equity shares of Rs,10/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 889,213,440 consisting 88,921,344 equity shares of Rs. 10/- each.20 Jan · Business
Press release dated January 20, 2010, titled "Lupin receives US FDA tentative approval for Memantine HC1 tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jan · Business
Press release dated January 20, 2010, titled "US FDA clears Lupin's Mandideep Facility". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Jan · Board meeting
Meeting on 29 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”5 Jan · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on January 05, 2010 has allotted 30460 fully paid up equity shares of Rs,10/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 889,057,270 consisting 88,905,727 equity shares of Rs. 10/- each.
Dec 2009
22 Dec · Business
Press release dated December 22, 2009, titled " Lupin Announces Litigation Settlement with Forest for Memantine Tablets." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Dec · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on December 18, 2009 has allotted 18838 fully paid up equity shares of Rs,10/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 888,752,670 consisting 88,875,267 equity shares of Rs. 10/- each.10 Dec · Foreign Currency Convertible Bonds
In January 2006, the Company had issued Foreign Currency Convertible Bonds (Bonds) of USD 100 million, with maturity in January 2011. The said Bonds were listed on the Singapore Stock Exchange Limited. Till date, Bonds aggregating USD 98.6 million have been converted. In accordance with the terms and conditions of the issue, the Company has now redeemed outstanding Bonds of USD 1.4 million. With the early redemption, there are no Bonds outstanding as on date
Nov 2009
30 Nov · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on November 30, 2009 has allotted 238,162 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Nov · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on November 05, 2009 has allotted 679,745 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Nov · Grant of Stock Options
The Company has granted 10000 options under 'Lupin Employees Stock Option Plan 2005' at the exercise price of Rs. 614.08 on November 04, 2009. Please note that one equity share of Rs.10/- each is covered by each option. The options issued are exercisable after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant
Oct 2009
28 Oct · Rating
ICRA Limited (ICRA) has assigned rating of "LAA+" (Pronounced "L Double A Plus") to the Company's Non Convertible Debenture programme of Rs. 500 crore. "LAA+" is the high-credit-quality rating assigned by ICRA to long-term debt instrument26 Oct · Business
Press release dated October 26, 2009, titled "Lupin Q2 Net Profit up 39%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Oct · Results
Standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 171777 lacs for half year ending on 30-SEP-2009 against Rs. 146510 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 27795 lacs for the half year ending on 30-SEP-2009 against Rs. 24046 lacs for the half year ending on 30-SEP-2008.26 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 80687 lacs for quarter ending on 30-SEP-2009 against Rs. 75268 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 9837 lacs for the quarter ending on 30-SEP-2009 against Rs. 13194 lacs for the quarter ending on 30-SEP-2008.26 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 111469 lacs for quarter ending on 30-SEP-2009 against Rs. 90837 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 16030 lacs for the quarter ending on 30-SEP-2009 against Rs. 11562 lacs for the quarter ending on 30-SEP-2008.26 Oct · Results
Consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 220028 lacs for half year ending on 30-SEP-2009 against Rs. 177069 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 30041 lacs for the half year ending on 30-SEP-2009 against Rs. 22766 lacs for the half year ending on 30-SEP-2008.21 Oct · Allotment of shares
Allotment Committee of Directors at its meeting held on October 21, 2009 has allotted 10,30,974 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Oct · Board meeting
Meeting on 26 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”8 Oct · Allotment of shares
Allotment Committee of Directors at its meeting held on October 08, 2009 has allotted 736,408 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Oct · Business
Press release dated October 05, 2009, titled "Lupin Licenses US Rights for Proprietary Bioadhesive Technology for Rifaximin to Salix Pharmaceuticals". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
29 Sep · Business
Press release dated September 28, 2009, titled "Lupin Expands Branded Play Announces Acquisition of US Rights to ANTARA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Sep · Updates
Lupin Pharmacare Limited and Lupin Herbal Limited, wholly-owned subsidiaries of Lupin Limited, have filed Applications before the Mumbai High Court, to amalgamate themselves with Lupin Limited w.e.f. April 1, 2009 ("Appointed Date"). We also wish to inform you that Novodigm Limited, another wholly-owned subsidiary of Lupin Limited, will shortly be filing an Application before the Ahmedabad High Court, to amalgamate itself with Lupin Limited w.e.f. April 1, 2009 ("Appointed Date"). The 'Effective Date' of amalgamation would be the date on which copies of the Orders passed by the Hon'ble High Courts of Mumbai and Ahmedabad sanctioning the Scheme of Amalgamation are filed with the Registrar of Companies, Maharashtra and Gujarat respectively25 Sep · Grant of Options
The Company has granted 80000 options to its employees under "Lupin Employees Stock Option Plan 2003" and 75350 options to the employees of its subsidiary companies under "Lupin Subsidiary Companies Stock Option Plan 2005" to its employees at the exercise price of Rs. 1089.15 on September 22, 2009. Please note that one equity share of Rs. 10/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant22 Sep · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on September 22, 2009 has allotted 620,940 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Sep · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on September 08, 2009 has allotted 864,993 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
25 Aug · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on August 25, 2009 has allotted 326,490 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Aug · Meeting
Minutes of the Annual General Meeting of the Company held on July 29, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Aug · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on August 10, 2009, has allotted 676,374 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Aug · Rating
ICRA Limited has assigned the rating of "A1+" (pronounced "A One Plus") to the Company's Short Term Debt (including Commercial Paper) programme of Rs.250 crore (Enhancement from Rs.100 crore). "A1+" is the highest-credit-quality rating assigned by ICRA to short term debt instruments
Jul 2009
29 Jul · Business
Press release dated July 29, 2009, titled "Lupin Net Profit up by 25% in Q1, FY 2009-10". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 91090 lacs for quarter ending on 30-JUN-2009 against Rs. 71242 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 17958 lacs for the quarter ending on 30-JUN-2009 against Rs. 10852 lacs for the quarter ending on 30-JUN-2008.29 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 108559 lacs for quarter ending on 30-JUN-2009 against Rs. 86232 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 14011 lacs for the quarter ending on 30-JUN-2009 against Rs. 11204 lacs for the quarter ending on 30-JUN-2008.15 Jul · Updates
Lupin Holdings B.V., (LHBV) Netherlands, the wholly-owned subsidiary of the Company, has transferred its holdings in Max Pharma Pty Ltd. (Max), Australia (another wholly-owned subsidiary company) to Generic Health Pty Ltd. (Generic), Australia, an associate of the Company. Consequently, LHBV's holding in Generic has increased from 38.45% to 48.11% and Max has ceased to be a subsidiary of the Company13 Jul · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on July 13, 2009 has allotted 5,36,457 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Jul · Board meeting
Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”9 Jul · Updates
Company has made arrangements for the payment of dividend within stipulated period subject to approval of the shareholders, at the ensuing Annual General Meeting to be held on July 29, 2009. The dividend (if declared) shall be remitted through ECS, wherever relevant bank details are available and the rest shall be paid through warrants / Pay orders payable at par, at all major centers. However, wherever the bank account particulars of the shareholders are not available with the Company, the dividend shall be issued through warrants payable at par, at centers mentioned in attached list, drawn on the Company's bankers viz "Citi Bank N.A.", with correspondent bank "Axis Bank Ltd". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). For more details click here.8 Jul · Corporate action
Board of Directors at their meeting held on May 13, 2009, have decided to close the Register of Members and Share Transfer Register from July 22, 2009 to July 29, 2009 (both days inclusive) for the purpose of Annual General Meeting and Dividend. The dividend (if declared) shall be remitted through ECS, wherever relevant bank details are available and the rest shall be paid through warrants / Pay orders payable at par, at all major centers.8 Jul · Meeting
Notice of the Annual General Meeting of the Shareholders of the Company to be held on July 29, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
30 Jun · Business
Press release dated June 30, 2009, titled "Lupin Expands Branded Play; Announces Acquisition of Worldwide Rights for its first NDA - AllerNaze". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jun · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on June 19, 2009 has allotted 3,11,816 fully paid up equity shares of Rs. 10/- each. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Jun · Grant of Stock Options
The Company has granted 28000 options under 'Lupin Employees Stock Option Plan 2005' to its employees at the exercise price of Rs. 840.85 on May 29, 2009.Please note that one equity share of Rs.10/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant
May 2009
27 May · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on May 27, 2009 has allotted 6120 fully paid up equity shares of Rs. 10/- each. These shares have been allotted upon exercising the options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the company has been increased to Rs. 828,340,700 consisting 82,834,070 equity shares of Rs. 10/- each.20 May · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of change in holdings of Equity Shares of Rs. 10/- each in the Company, of Officers of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 May · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of change in holdings of Equity Shares of Rs. 10/- each in the Company, of Officers of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 May · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of change in holdings of Equity Shares of Rs. 10/- each in the Company, of Officers of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.